Sergey V. Kashin
Research Subjects
Sergey V. Kashin has a total of 180 co-authors. Here are the top co-authors by number of shared publications:
- Roman O. Kuvaev
Pirogov Russian National Research Medical University
11 shared publications - Dmitriy V. Zavyalov
Yaroslavl State Medical University
10 shared publications - E.A. Kraynova
Moscow City Oncology Hospital No. 62
4 shared publications - Evgeniy L. Nikonov
Pirogov Russian National Research Medical University
4 shared publications - Evgeniy L. Nikonov
Pirogov Russian National Research Medical University
4 shared publications - Maria E. Zharova
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
4 shared publications
Latest Publications
- 6 October 2026
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 15 (3)
Bowel preparation for colonoscopy: current strategies. A narrative review
Objective. To summarize current evidence on the principles of bowel preparation for colonoscopy. Key points. The quality of bowel cleansing is an independent quality indicator of colonoscopy and affects mucosal visualization, detection of colorectal neoplasia, and the need for repeat examination. Current international guidelines consider split-dose regimens preferable for elective colonoscopy, whereas a same-day morning regimen is mainly acceptable for procedures scheduled in the afternoon. The last dose of the bowel-cleansing agent should preferably be started within 5 hours before colonoscopy and completed at least 2 hours before the procedure. Selection of the bowel preparation should take into account age, chronic constipation, diabetes mellitus, chronic kidney disease, cardiovascular comorbidity, concomitant medications, and the risk of fluid and electrolyte disturbances. Iso-osmotic polyethylene glycol solutions with electrolytes, together with low-volume polyethylene glycol preparations containing ascorbate, remain important first-line options because of their established efficacy and predictable safety profile. The macrogol 4000 and electrolyte preparation Lavacol is registered both for bowel cleansing and for the symptomatic treatment of constipation, which may be of practical relevance in patients prone to constipation. Low-volume sulfate-based preparations provide effective bowel cleansing but require adequate additional hydration and should be used cautiously in older and comorbid patients because of the risk of fluid and electrolyte disturbances. Conclusion. Optimal bowel preparation for colonoscopy should be individualized and include assessment of risk factors, appropriate dietary modification, preferential use of a split-dose regimen, and selection of the preparation according to the patient’s clinical profile. Standardization of these measures may improve the rate of adequate bowel cleansing and the diagnostic yield of colonoscopy.
- 6 October 2026
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 15 (3)
Bowel preparation for colonoscopy: current strategies. A narrative review
Objective. To summarize current evidence on the principles of bowel preparation for colonoscopy. Key points. The quality of bowel cleansing is an independent quality indicator of colonoscopy and affects mucosal visualization, detection of colorectal neoplasia, and the need for repeat examination. Current international guidelines consider split-dose regimens preferable for elective colonoscopy, whereas a same-day morning regimen is mainly acceptable for procedures scheduled in the afternoon. The last dose of the bowel-cleansing agent should preferably be started within 5 hours before colonoscopy and completed at least 2 hours before the procedure. Selection of the bowel preparation should take into account age, chronic constipation, diabetes mellitus, chronic kidney disease, cardiovascular comorbidity, concomitant medications, and the risk of fluid and electrolyte disturbances. Iso-osmotic polyethylene glycol solutions with electrolytes, together with low-volume polyethylene glycol preparations containing ascorbate, remain important first-line options because of their established efficacy and predictable safety profile. The macrogol 4000 and electrolyte preparation Lavacol is registered both for bowel cleansing and for the symptomatic treatment of constipation, which may be of practical relevance in patients prone to constipation. Low-volume sulfate-based preparations provide effective bowel cleansing but require adequate additional hydration and should be used cautiously in older and comorbid patients because of the risk of fluid and electrolyte disturbances. Conclusion. Optimal bowel preparation for colonoscopy should be individualized and include assessment of risk factors, appropriate dietary modification, preferential use of a split-dose regimen, and selection of the preparation according to the patient’s clinical profile. Standardization of these measures may improve the rate of adequate bowel cleansing and the diagnostic yield of colonoscopy.
- 16 June 2026
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 15 (2) , 73-80
The main statements of the current recommendations of the World Endoscopy Organization on the diagnosis and management of patients with Barrett’s esophagus
This article summarizes current standards for the diagnosis of Barrett’s esophagus and the management of affected patients, as developed and published by the expert panel of the Esophageal Diseases Committee of the World Endoscopy Organization. The panel aimed to formulate updated, evidence-based recommendations; to provide a precise description of the key anatomical landmarks relevant to the diagnosis of esophageal pathology; and to facilitate their consistent use in standardized endoscopic reporting. Particular emphasis is placed on improving the endoscopic diagnosis of precancerous lesions and early esophageal cancer. From both endoscopic and histopathological perspectives, Barrett’s esophagus is defined as a segment of columnar metaplastic epithelium in the distal esophagus, measuring at least 1 cm in length, that is identified endoscopically proximal to the esophagogastric junction and confirmed histologically by examination of biopsy specimens. Current clinical guidelines in most countries require histological confirmation of intestinal-type metaplasia of the esophageal mucosa to establish a diagnosis of Barrett’s esophagus, as this is the only type of columnar epithelium associated with an increased risk of malignant transformation. Areas of columnar epithelium with intestinal metaplasia measuring less than 1 cm, located in the gastric cardia or appearing as “tongues” of columnar epithelium at an irregular squamocolumnar junction, are not associated with an increased risk of esophageal adenocarcinoma and are classified as foci of intestinal metaplasia of the esophagogastric junction. The importance of studying and refining diagnostic and therapeutic strategies for Barrett’s esophagus is evident, given the rising incidence of esophageal adenocarcinoma in developed countries and the high mortality associated with this malignancy. Despite substantial progress in the diagnosis and treatment of Barrett’s esophagus, standardized definitions, accurate recognition of endoscopic landmarks, and consistent application of classification systems remain essential. Persisting inconsistencies in the core definitions of Barrett’s esophagus, together with insufficient awareness and understanding of relevant anatomical landmarks, continue to hinder uniformity in endoscopic medical documentation. Following a comprehensive review of this condition, the World Endoscopy Organization expert panel reached consensus on six key endoscopic landmarks for the assessment of Barrett’s esophagus. These include the palisade vessels, the esophagogastric junction (EGJ), the squamocolumnar junction, or Z-line, the location of the lesion, extrinsic compression of the esophageal wall by adjacent organs and vessels, and orientation of the endoscopic image by quadrants, corresponding to quarters of the esophageal circumference. The panel also defined 13 key terms: Barrett’s esophagus, hiatal hernia, squamous islands, columnar metaplastic islands, complete endoscopic resection, endoscopic resection, endoscopic ablation, systematic inspection protocol, complete eradication of intestinal metaplasia and dysplasia, residual foci, recurrence of areas of columnar metaplasia, and failed endoscopic treatment. Four principal classification systems were identified for describing Barrett’s esophagus and manifestations of reflux disease: the Prague classification, the Los Angeles classification, the Paris classification, and the classification proposed by the Barrett’s International NBI Group (BING; NBI, narrow-band imaging). Thus, the World Endoscopy Organization expert panel has outlined the key provisions of the updated recommendations, including endoscopic anatomical landmarks, definitions, and classification systems used in the diagnosis and description of Barrett’s esophagus. These evidence-based recommendations are intended to improve the quality of diagnosis and endoscopic assessment of Barrett’s esophagus, a condition regarded as the only facultative precancerous disorder characterized by multistep neoplastic progression. Implementation of these standards may support more accurate diagnosis and promote uniform endoscopic reporting of Barrett’s esophagus across healthcare institutions.
- 16 June 2026
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 15 (2) , 73-80
The main statements of the current recommendations of the World Endoscopy Organization on the diagnosis and management of patients with Barrett’s esophagus
This article summarizes current standards for the diagnosis of Barrett’s esophagus and the management of affected patients, as developed and published by the expert panel of the Esophageal Diseases Committee of the World Endoscopy Organization. The panel aimed to formulate updated, evidence-based recommendations; to provide a precise description of the key anatomical landmarks relevant to the diagnosis of esophageal pathology; and to facilitate their consistent use in standardized endoscopic reporting. Particular emphasis is placed on improving the endoscopic diagnosis of precancerous lesions and early esophageal cancer. From both endoscopic and histopathological perspectives, Barrett’s esophagus is defined as a segment of columnar metaplastic epithelium in the distal esophagus, measuring at least 1 cm in length, that is identified endoscopically proximal to the esophagogastric junction and confirmed histologically by examination of biopsy specimens. Current clinical guidelines in most countries require histological confirmation of intestinal-type metaplasia of the esophageal mucosa to establish a diagnosis of Barrett’s esophagus, as this is the only type of columnar epithelium associated with an increased risk of malignant transformation. Areas of columnar epithelium with intestinal metaplasia measuring less than 1 cm, located in the gastric cardia or appearing as “tongues” of columnar epithelium at an irregular squamocolumnar junction, are not associated with an increased risk of esophageal adenocarcinoma and are classified as foci of intestinal metaplasia of the esophagogastric junction. The importance of studying and refining diagnostic and therapeutic strategies for Barrett’s esophagus is evident, given the rising incidence of esophageal adenocarcinoma in developed countries and the high mortality associated with this malignancy. Despite substantial progress in the diagnosis and treatment of Barrett’s esophagus, standardized definitions, accurate recognition of endoscopic landmarks, and consistent application of classification systems remain essential. Persisting inconsistencies in the core definitions of Barrett’s esophagus, together with insufficient awareness and understanding of relevant anatomical landmarks, continue to hinder uniformity in endoscopic medical documentation. Following a comprehensive review of this condition, the World Endoscopy Organization expert panel reached consensus on six key endoscopic landmarks for the assessment of Barrett’s esophagus. These include the palisade vessels, the esophagogastric junction (EGJ), the squamocolumnar junction, or Z-line, the location of the lesion, extrinsic compression of the esophageal wall by adjacent organs and vessels, and orientation of the endoscopic image by quadrants, corresponding to quarters of the esophageal circumference. The panel also defined 13 key terms: Barrett’s esophagus, hiatal hernia, squamous islands, columnar metaplastic islands, complete endoscopic resection, endoscopic resection, endoscopic ablation, systematic inspection protocol, complete eradication of intestinal metaplasia and dysplasia, residual foci, recurrence of areas of columnar metaplasia, and failed endoscopic treatment. Four principal classification systems were identified for describing Barrett’s esophagus and manifestations of reflux disease: the Prague classification, the Los Angeles classification, the Paris classification, and the classification proposed by the Barrett’s International NBI Group (BING; NBI, narrow-band imaging). Thus, the World Endoscopy Organization expert panel has outlined the key provisions of the updated recommendations, including endoscopic anatomical landmarks, definitions, and classification systems used in the diagnosis and description of Barrett’s esophagus. These evidence-based recommendations are intended to improve the quality of diagnosis and endoscopic assessment of Barrett’s esophagus, a condition regarded as the only facultative precancerous disorder characterized by multistep neoplastic progression. Implementation of these standards may support more accurate diagnosis and promote uniform endoscopic reporting of Barrett’s esophagus across healthcare institutions.
- 30 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 14 (4) , 66-75
«Glomus-like lesions» of the gastric fundic type mucosa — a novel endoscopic sign of autoimmune atrophic gastritis
Objective. To assess the diagnostic value of a novel endoscopic feature — glomus-like lesions (GLL) of the gastric mucosa in the fundus and body — for the detection of autoimmune atrophic gastritis (AIG). Material and methods. The study included 111 patients with chronic atrophic gastritis (29 men and 82 women; mean age 57.7±10.6 years). AIG was diagnosed in 57 patients, while 54 patients had Helicobacter pylori — associated chronic multifocal atrophic gastritis (MAG). All patients underwent upper gastrointestinal endoscopy using standard white-light imaging, followed by magnified evaluation using optical image-enhancement techniques (NBI, BLI, or i-scan OE). Histological verification included targeted forceps biopsies or endoscopic mucosal resection from areas with GLL, as well as random biopsies from the antrum and corpus. Results. GLL were identified in 44 (77.2%) patients with AIG and in all patients with neuroendocrine tumors (NETs), whereas none of the 54 patients with MAG exhibited this feature (p=0.0001). Histological analysis of GLL-positive areas consistently revealed fundic gland atrophy, enterochromaffin-like (ECL) cell hyperplasia, and foveolar epithelial retention cysts. The sensitivity, specificity, and overall accuracy of GLL for diagnosing AIG were 0.77, 1.00, and 0.88, respectively. The positive and negative predictive values were 1.00 and 0.81. Conclusion. This study presents the first detailed description of glomus-like lesions as a novel endoscopic marker of AIG. GLL represent a highly specific feature of AIG, correlate with its characteristic histopathological changes, and may facilitate earlier identification of NETs in this patient population.
- 30 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 14 (4) , 66-75
«Glomus-like lesions» of the gastric fundic type mucosa — a novel endoscopic sign of autoimmune atrophic gastritis
Objective. To assess the diagnostic value of a novel endoscopic feature — glomus-like lesions (GLL) of the gastric mucosa in the fundus and body — for the detection of autoimmune atrophic gastritis (AIG). Material and methods. The study included 111 patients with chronic atrophic gastritis (29 men and 82 women; mean age 57.7±10.6 years). AIG was diagnosed in 57 patients, while 54 patients had Helicobacter pylori — associated chronic multifocal atrophic gastritis (MAG). All patients underwent upper gastrointestinal endoscopy using standard white-light imaging, followed by magnified evaluation using optical image-enhancement techniques (NBI, BLI, or i-scan OE). Histological verification included targeted forceps biopsies or endoscopic mucosal resection from areas with GLL, as well as random biopsies from the antrum and corpus. Results. GLL were identified in 44 (77.2%) patients with AIG and in all patients with neuroendocrine tumors (NETs), whereas none of the 54 patients with MAG exhibited this feature (p=0.0001). Histological analysis of GLL-positive areas consistently revealed fundic gland atrophy, enterochromaffin-like (ECL) cell hyperplasia, and foveolar epithelial retention cysts. The sensitivity, specificity, and overall accuracy of GLL for diagnosing AIG were 0.77, 1.00, and 0.88, respectively. The positive and negative predictive values were 1.00 and 0.81. Conclusion. This study presents the first detailed description of glomus-like lesions as a novel endoscopic marker of AIG. GLL represent a highly specific feature of AIG, correlate with its characteristic histopathological changes, and may facilitate earlier identification of NETs in this patient population.
- 30 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 14 (4) , 56-64
Assessing quality indicators of screening colonoscopy using an artificial intelligence system
The efficacy of screening colonoscopy is contingent upon adherence to established quality indicators, including cecal intubation (CIR) and adenoma detection rate (ADR). Artificial intelligence (AI) presents a viable means of automating the assessment of these metrics. Objective. To evaluate the feasibility of an AI system for automated assessment of CIR and ADR with preliminary estimation of invasive growth. Materials and Methods. A prospective single-center study was conducted using photo and video materials from colonoscopies performed at the Yaroslavl Regional Clinical Oncology Hospital. High-quality visualization of the colonic mucosa was ensured through a bowel preparation regimen using low-volume trisulfate solution (Eziclen) in split dose combined with Meteospazmil. The AI model was trained on endoscopic images of the appendiceal orifice, colorectal neoplasms, and normal mucosa. Results. The AI algorithm was integrated into the endoscopy processor. It provided real-time visual assistance, displaying a blue perimeter frame upon cecal intubation confirmation. The model demonstrated high performance: AUC 0.97 (F1=0.85) on the validation dataset and AUC 0.95 (F1=0.90) on the test dataset. The mean processing time per frame (29 ms) enabled real-time operationFor detected adenomas, the system annotated the lesion with a yellow bounding box and provided a probability for superficial versus deep submucosal invasion. The high detection rate was facilitated by optimal bowel preparation quality. Conclusion. This AI system provides objective, real-time quality assurance by verifying procedural completeness and detecting adenomas. Its application facilitates standardized auditing, automated documentation, and enhanced endoscopic training, addressing the growing demand on endoscopy services.
- 30 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 14 (4) , 56-64
Assessing quality indicators of screening colonoscopy using an artificial intelligence system
The efficacy of screening colonoscopy is contingent upon adherence to established quality indicators, including cecal intubation (CIR) and adenoma detection rate (ADR). Artificial intelligence (AI) presents a viable means of automating the assessment of these metrics. Objective. To evaluate the feasibility of an AI system for automated assessment of CIR and ADR with preliminary estimation of invasive growth. Materials and Methods. A prospective single-center study was conducted using photo and video materials from colonoscopies performed at the Yaroslavl Regional Clinical Oncology Hospital. High-quality visualization of the colonic mucosa was ensured through a bowel preparation regimen using low-volume trisulfate solution (Eziclen) in split dose combined with Meteospazmil. The AI model was trained on endoscopic images of the appendiceal orifice, colorectal neoplasms, and normal mucosa. Results. The AI algorithm was integrated into the endoscopy processor. It provided real-time visual assistance, displaying a blue perimeter frame upon cecal intubation confirmation. The model demonstrated high performance: AUC 0.97 (F1=0.85) on the validation dataset and AUC 0.95 (F1=0.90) on the test dataset. The mean processing time per frame (29 ms) enabled real-time operationFor detected adenomas, the system annotated the lesion with a yellow bounding box and provided a probability for superficial versus deep submucosal invasion. The high detection rate was facilitated by optimal bowel preparation quality. Conclusion. This AI system provides objective, real-time quality assurance by verifying procedural completeness and detecting adenomas. Its application facilitates standardized auditing, automated documentation, and enhanced endoscopic training, addressing the growing demand on endoscopy services.
- Open Access
- 18 November 2025
- Published by LLC Global Media Technology in Filin’s Clinical endoscopy
- Vol. 67 (3) , 23-35
Complications of endoscopic interventions in the lower gastrointestinal tract
The Federal Law No. 323-FZ of November 21, 2011 establishes the requirements for the content and format of the “Informed Voluntary Consent” (IVC) form for medical interventions. This document serves as a legal guarantee of protecting the rights of both patients and healthcare professionals. The article discusses the procedure of signing the IVC and highlights its key sections that require special consideration. The most important are the sections “Indications” and “Contraindications for medical intervention.” Indications provide patients with information about the necessity of a particular procedure and the possible consequences of refusal, ensuring awareness and informed decision-making. The section on contraindications reflects potential health and life risks related to the patient’s condition or to the specifics of the intervention, including possible complications. The patient’s signature confirms awareness and consent, while also providing legal protection for the healthcare institution and staff in case of adverse outcomes or legal disputes. Special attention is paid to the section “Risks associated with medical care.” The list of potential adverse events (for example, during colonoscopy) can be extensive, which makes it impossible to include every detail. Therefore, the authors propose standardization and adaptation of such risks for inclusion in the IVC form. This approach allows achieving a balance between comprehensive patient information and practical usability of the document.
- 18 November 2025
- Published by LLC Global Media Technology in Filin’s Clinical endoscopy
- Vol. 67 (3) , 23-35
Open AccessComplications of endoscopic interventions in the lower gastrointestinal tract
The Federal Law No. 323-FZ of November 21, 2011 establishes the requirements for the content and format of the “Informed Voluntary Consent” (IVC) form for medical interventions. This document serves as a legal guarantee of protecting the rights of both patients and healthcare professionals. The article discusses the procedure of signing the IVC and highlights its key sections that require special consideration. The most important are the sections “Indications” and “Contraindications for medical intervention.” Indications provide patients with information about the necessity of a particular procedure and the possible consequences of refusal, ensuring awareness and informed decision-making. The section on contraindications reflects potential health and life risks related to the patient’s condition or to the specifics of the intervention, including possible complications. The patient’s signature confirms awareness and consent, while also providing legal protection for the healthcare institution and staff in case of adverse outcomes or legal disputes. Special attention is paid to the section “Risks associated with medical care.” The list of potential adverse events (for example, during colonoscopy) can be extensive, which makes it impossible to include every detail. Therefore, the authors propose standardization and adaptation of such risks for inclusion in the IVC form. This approach allows achieving a balance between comprehensive patient information and practical usability of the document.
- Open Access
- 18 October 2025
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 2 (3) , 281-294
The main provisions of the guidelines of the National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of Russia on the population-based colorectal cancer screening
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths both globally and in Russia. Screening is a key element in the prevention and early diagnosis of CRC. This guide presents current guidelines aimed at managing effective CRC screening among the adult population as part of routine health examinations. The primary goal of screening is to identify precancerous conditions and early stages of CRC for timely treatment and an improved prognosis. The guidelines include a list of target groups, particularly individuals aged 40 to 75 years, as well as individuals with a family history or other risk factors. The key screening method is a immunochemical fecal occult blood test, followed by a colonoscopy in positive results. Particular attention is paid to compliance with standards for the preparation and conduct of examinations. The guidelines outline the stages of patient care, from initial identification to specialized treatment, including regulatory frameworks and the use of information systems for monitoring and reporting outcomes. These guidelines are rested on evidence-based medicine and are an essential tool for primary care specialists and healthcare executives.
- 18 October 2025
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 2 (3) , 281-294
Open AccessThe main provisions of the guidelines of the National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of Russia on the population-based colorectal cancer screening
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths both globally and in Russia. Screening is a key element in the prevention and early diagnosis of CRC. This guide presents current guidelines aimed at managing effective CRC screening among the adult population as part of routine health examinations. The primary goal of screening is to identify precancerous conditions and early stages of CRC for timely treatment and an improved prognosis. The guidelines include a list of target groups, particularly individuals aged 40 to 75 years, as well as individuals with a family history or other risk factors. The key screening method is a immunochemical fecal occult blood test, followed by a colonoscopy in positive results. Particular attention is paid to compliance with standards for the preparation and conduct of examinations. The guidelines outline the stages of patient care, from initial identification to specialized treatment, including regulatory frameworks and the use of information systems for monitoring and reporting outcomes. These guidelines are rested on evidence-based medicine and are an essential tool for primary care specialists and healthcare executives.
- Open Access
- 18 October 2025
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 2 (3) , 281-294
The main provisions of the guidelines of the National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of Russia on the population-based colorectal cancer screening
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths both globally and in Russia. Screening is a key element in the prevention and early diagnosis of CRC. This guide presents current guidelines aimed at managing effective CRC screening among the adult population as part of routine health examinations.The primary goal of screening is to identify precancerous conditions and early stages of CRC for timely treatment and an improved prognosis. The guidelines include a list of target groups, particularly individuals aged 40 to 75 years, as well as individuals with a family history or other risk factors.The key screening method is a immunochemical fecal occult blood test, followed by a colonoscopy in positive results. Particular attention is paid to compliance with standards for the preparation and conduct of examinations.The guidelines outline the stages of patient care, from initial identification to specialized treatment, including regulatory frameworks and the use of information systems for monitoring and reporting outcomes.These guidelines are rested on evidence-based medicine and are an essential tool for primary care specialists and healthcare executives.
- 18 October 2025
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 2 (3) , 281-294
Open AccessThe main provisions of the guidelines of the National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of Russia on the population-based colorectal cancer screening
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths both globally and in Russia. Screening is a key element in the prevention and early diagnosis of CRC. This guide presents current guidelines aimed at managing effective CRC screening among the adult population as part of routine health examinations.The primary goal of screening is to identify precancerous conditions and early stages of CRC for timely treatment and an improved prognosis. The guidelines include a list of target groups, particularly individuals aged 40 to 75 years, as well as individuals with a family history or other risk factors.The key screening method is a immunochemical fecal occult blood test, followed by a colonoscopy in positive results. Particular attention is paid to compliance with standards for the preparation and conduct of examinations.The guidelines outline the stages of patient care, from initial identification to specialized treatment, including regulatory frameworks and the use of information systems for monitoring and reporting outcomes.These guidelines are rested on evidence-based medicine and are an essential tool for primary care specialists and healthcare executives.
- 28 July 2025
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 28 (7)
Multicentric polymorphic gastric cancer on the background of the autoimmune gastritis
Autoimmune gastritis (AIG) is a chronic inflammatory disease characterized by atrophy of the acid-producing mucosa of the stomach body as a result of autoimmune damage to the parietal cells. In presence of long-lasting AIG, development of epithelial neoplasms, including hyperplastic polyps and neoplastic processes, is possible, that significantly complicates timely diagnosis of malignant gastric neoplasms. Objective. To present a clinical case of multicentric polymorphic stomach cancer developed in addition to AIG with emphasis on diagnostic difficulties and the need to comply with regular medical check-up standards. Case report. Patient, 66 years old, has been under outpatient follow-up since 2010 for B12-deficiency and iron deficiency anemia, autoimmune thyroiditis, chronic gastritis and gastric polyposis. However, the patient did not receive sufficient medical care. 15 years after the establishment of «chronic gastritis» diagnosis, multicentric polymorphic stomach cancer in presence of AIG has been revealed when reffering to oncological clinic. Gastrectomy with D2 lymph node dissection was performed. According to the results of histological study, the following diagnosis was established: multicentric polymorphic cancer of the stomach body with cT1a(m)pN0M0, stage I, clinical group 2 [C16.8], including well-differentiated adenocarcinoma G1 (intestinal type according to Lauren), poorly differentiated signet ring cell adenocarcinoma G3 (diffuse type according to Lauren), as well as neuroendocrine tumors of the stomach G2. Conclusion. This clinical case emphasizes the complexity of early diagnosis of autoimmune gastritis and keeps up to date the importance of adherence to diagnostic algorithms and follow-up standards for patients with chronic gastritis.
- 28 July 2025
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 28 (7)
Multicentric polymorphic gastric cancer on the background of the autoimmune gastritis
Autoimmune gastritis (AIG) is a chronic inflammatory disease characterized by atrophy of the acid-producing mucosa of the stomach body as a result of autoimmune damage to the parietal cells. In presence of long-lasting AIG, development of epithelial neoplasms, including hyperplastic polyps and neoplastic processes, is possible, that significantly complicates timely diagnosis of malignant gastric neoplasms. Objective. To present a clinical case of multicentric polymorphic stomach cancer developed in addition to AIG with emphasis on diagnostic difficulties and the need to comply with regular medical check-up standards. Case report. Patient, 66 years old, has been under outpatient follow-up since 2010 for B12-deficiency and iron deficiency anemia, autoimmune thyroiditis, chronic gastritis and gastric polyposis. However, the patient did not receive sufficient medical care. 15 years after the establishment of «chronic gastritis» diagnosis, multicentric polymorphic stomach cancer in presence of AIG has been revealed when reffering to oncological clinic. Gastrectomy with D2 lymph node dissection was performed. According to the results of histological study, the following diagnosis was established: multicentric polymorphic cancer of the stomach body with cT1a(m)pN0M0, stage I, clinical group 2 [C16.8], including well-differentiated adenocarcinoma G1 (intestinal type according to Lauren), poorly differentiated signet ring cell adenocarcinoma G3 (diffuse type according to Lauren), as well as neuroendocrine tumors of the stomach G2. Conclusion. This clinical case emphasizes the complexity of early diagnosis of autoimmune gastritis and keeps up to date the importance of adherence to diagnostic algorithms and follow-up standards for patients with chronic gastritis.
- 16 June 2025
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 14 (2)
Complications in diagnostic and therapeutic endoscopic procedures on the lower gastrointestinal tract. Collegial discussion of informed consent by the Association of Quality Care Experts
This article examines the key legal and medical requirements for drafting informed consent (IC) forms for diagnostic and therapeutic endoscopic procedures on the lower gastrointestinal tract (GIT). Special attention is paid to the importance of standardizing the approach to documenting indications, contraindications, and potential complications in IC forms to enhance patient safety and protect healthcare institutions. The authors analyze Russian and international data, emphasizing the necessity of effectively informing patients about the risks of endoscopic procedures, including possible adverse events (AEs) such as perforation, bleeding, and infectious complications. The article highlights that drafting IC forms must consider legislative requirements, clinical guidelines, and up-to-date safety data. Recommendations are provided for minimizing AE risks through staged patient assessments, tailored selection of tools and methods, and enhancing the training of medical personnel. This article serves as a valuable resource for endoscopists, legal experts, and healthcare administrators committed to improving the quality and safety of medical care. The material is accompanied by practical examples and a review of complications associated with colonoscopy.
- 16 June 2025
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 14 (2)
Complications in diagnostic and therapeutic endoscopic procedures on the lower gastrointestinal tract. Collegial discussion of informed consent by the Association of Quality Care Experts
This article examines the key legal and medical requirements for drafting informed consent (IC) forms for diagnostic and therapeutic endoscopic procedures on the lower gastrointestinal tract (GIT). Special attention is paid to the importance of standardizing the approach to documenting indications, contraindications, and potential complications in IC forms to enhance patient safety and protect healthcare institutions. The authors analyze Russian and international data, emphasizing the necessity of effectively informing patients about the risks of endoscopic procedures, including possible adverse events (AEs) such as perforation, bleeding, and infectious complications. The article highlights that drafting IC forms must consider legislative requirements, clinical guidelines, and up-to-date safety data. Recommendations are provided for minimizing AE risks through staged patient assessments, tailored selection of tools and methods, and enhancing the training of medical personnel. This article serves as a valuable resource for endoscopists, legal experts, and healthcare administrators committed to improving the quality and safety of medical care. The material is accompanied by practical examples and a review of complications associated with colonoscopy.
- 17 December 2024
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 13 (4)
Early detection of gastrointestinal cancer: opportunities for the development of endoscopic services in the Russian Federation
Oncological diseases remain a leading cause of mortality globally and in Russia. In 2022, gastrointestinal tract (GIT) cancers accounted for 17% of all malignancies in Russia. The late detection of GIT cancers is of particular concern, as it significantly reduces the chances of successful treatment. Enhancing endoscopic services can improve early diagnosis and treatment outcomes. Objective. To highlight opportunities for developing endoscopic services in the Russian Federation for the early detection of GIT cancers. Key points. This article explores the challenges in diagnosing and treating GIT cancers in Russia, reviewing trends in incidence and mortality. It emphasizes the critical role of early detection, highlighting the limitations in the capacity of endoscopic services, such as personnel shortages and resource constraints. The article references successful screening programs in countries like Japan and South Korea, where modern endoscopic techniques, including narrow-band imaging and artificial intelligence technologies, are utilized. Proposed measures for improving endoscopic services aim to enhance the detection of precancerous lesions and early-stage cancers. Conclusion. Early detection and screening for GIT cancers is a key public health goal in Russia. Modernizing endoscopic services, implementing advanced technologies, and raising public awareness can significantly reduce mortality from these diseases. Achieving these goals requires a comprehensive approach involving medical community and government support.
- 17 December 2024
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 13 (4)
Early detection of gastrointestinal cancer: opportunities for the development of endoscopic services in the Russian Federation
Oncological diseases remain a leading cause of mortality globally and in Russia. In 2022, gastrointestinal tract (GIT) cancers accounted for 17% of all malignancies in Russia. The late detection of GIT cancers is of particular concern, as it significantly reduces the chances of successful treatment. Enhancing endoscopic services can improve early diagnosis and treatment outcomes. Objective. To highlight opportunities for developing endoscopic services in the Russian Federation for the early detection of GIT cancers. Key points. This article explores the challenges in diagnosing and treating GIT cancers in Russia, reviewing trends in incidence and mortality. It emphasizes the critical role of early detection, highlighting the limitations in the capacity of endoscopic services, such as personnel shortages and resource constraints. The article references successful screening programs in countries like Japan and South Korea, where modern endoscopic techniques, including narrow-band imaging and artificial intelligence technologies, are utilized. Proposed measures for improving endoscopic services aim to enhance the detection of precancerous lesions and early-stage cancers. Conclusion. Early detection and screening for GIT cancers is a key public health goal in Russia. Modernizing endoscopic services, implementing advanced technologies, and raising public awareness can significantly reduce mortality from these diseases. Achieving these goals requires a comprehensive approach involving medical community and government support.